Clinical trial
An Open-label Follow-up Study of 0.01 mg/kg/Day to 0.03 mg/kg/Day Prucalopride (R108512) Oral Solution in Paediatric Subjects, Aged >= 4 to <= 12 Years With Functional Faecal Retention (FFR), Who Participated in the PRU-USA-12.
NCT01670669 is registered in ClinicalTrials.gov with Movetis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Follow-up Study of 0.01 mg/kg/Day to 0.03 mg/kg/Day Prucalopride (R108512) Oral Solution in Paediatric Subjects, Aged >= 4 to <= 12 Years With Functional Faecal Retention (FFR), Who Participated in the PRU-USA-12.
- Lead sponsor
- Movetis
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 1998
- Completion date
- July 31, 1999
- Enrollment
- 37 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.